Welcome to our dedicated page for NANALYSIS SCIENTIFIC news (Ticker: NSCIF), a resource for investors and traders seeking the latest updates and insights on NANALYSIS SCIENTIFIC stock.
Nanalysis Scientific Corp. is a leading provider of portable NMR machines and MRI technology for industrial and research applications. The company operates in two primary segments: Scientific Equipment and Security Services. In the Scientific Equipment business, Nanalysis develops and manufactures portable NMR spectrometers for laboratory and industrial markets. Their products are used in various industries and research labs globally. Recently, the company achieved significant revenue growth, introduced new innovative products, and expanded its Security Services business through a multi-million dollar government contract.
Nanalysis Scientific Corp. will host a conference call on May 31, 2022, at 5:00 PM ET to discuss the quarterly results ending March 31. The call is accessible via phone and a listen-only webcast. The Annual General Meeting (AGM) is set for June 22, 2022, at 11:00 AM ET, with shareholders encouraged to vote by proxy due to health concerns. Nanalysis, trading as OTCQX: NSCIF, specializes in portable NMR and MRI technologies.
Nanalysis Scientific Corp. (OTCQX:NSCIF) will present at the Planet MicroCap Showcase 2022 on May 4, 2022, at 5:30 PM PT in Las Vegas. CEO Sean Krakiwsky will lead the presentation and engage in one-on-one investor meetings. The event will be accessible via a live webcast. Nanalysis is recognized for its innovative portable NMR technology, serving industries such as pharma, biotech, and oil & gas. The company continues to enhance its product offerings, including a new 100MHz NMR device, reinforcing its position in the market.
Nanalysis Scientific Corp. announced its financial results for Q4 and full year of 2021, showcasing a remarkable 104% revenue growth to $16,043K. The company improved its net loss to $1,772K from a previous loss, while gross margins slightly decreased from 66% to 64%. Strategic highlights included a $4.98 million funding commitment from the Canadian government and acquisitions of K’Prime Technologies and Quad Systems. The firm is optimistic about future growth, supported by a healthy balance sheet and strong product demand.
Nanalysis Scientific Corp. will release its fourth quarter and full year results for the year ending December 31, 2021 on Thursday, April 28, 2022, followed by a conference call at 5 PM ET. CEO Sean Krakiwsky and CFO Luke Caplette will lead the call. Investors can participate via phone or through a webcast. The release will provide insights into the company's financial performance and future strategies as a leader in portable MRI and NMR technology.
Nanalysis Scientific Corp. (OTCQX:NSCIF, TSXV:NSCI) will be presenting at NobleCon18 on April 22, 2022, at 12:30 PM ET in Hollywood, Florida. CEO Sean Krakiwsky will also hold breakout sessions on April 20 and April 21 at various times. The presentation will be available via a high-definition video webcast the following day, accessible through Noble Capital Markets' website and Channelchek. Nanalysis specializes in portable Nuclear Magnetic Resonance (NMR) devices and aims to expand its market reach in multiple industries.
Nanalysis Scientific Corp. has secured $4,985,000 from the Canadian government to enhance its manufacturing operations and expand into global markets for nuclear magnetic resonance products. This funding, provided through Prairies Economic Development Canada, will be accessed over three years with interest-free repayments starting on September 1, 2025. The CEO, Sean Krakiwsky, expressed gratitude for this support, indicating it will help drive growth and innovation while mitigating supply chain risks. The Company focuses on developing portable NMR spectrometers for various industries.
Nanalysis Scientific Corp. announced a significant equity investment in Quad Systems AG, acquiring a 43% ownership stake along with an option to purchase the remaining shares. The company provided a CHF 1,000,000 convertible loan to Quad Systems and subscribed for shares totaling CHF 6,500,000. This investment is expected to enhance product offerings and support business growth. Nanalysis will appoint two representatives to Quad Systems' Board of Directors and has rights for future offers until July 1, 2023.
Nanalysis Scientific Corp. (OTCQX:NSCIF) announced the granting of 620,000 stock options to directors and officers at an exercise price of $1.32 per share, valid for five years. The options will vest in three stages: one-third after 12, 24, and 36 months. This strategic move aims to incentivize leadership and align their interests with shareholders.
FAQ
What is the current stock price of NANALYSIS SCIENTIFIC (NSCIF)?
What is the market cap of NANALYSIS SCIENTIFIC (NSCIF)?
What does Nanalysis Scientific Corp. specialize in?
In which industries are Nanalysis products used?
What recent achievements has Nanalysis Scientific Corp. made?
What are the core business segments of Nanalysis?
What sets Nanalysis Scientific Corp. apart in the market?
How can investors participate in Nanalysis updates and calls?
What financial highlights has Nanalysis recently reported?
What is the significance of the recent stock options grant by Nanalysis?
